MAPT and frontotemporal dementia: Moreover, phosphorylated Tau levels are widely used as an indicator of neurodegeneration, in particular the phosphorylated epitope evaluated in this work (Ser396 in human sequence), which is implicated in the pathophysiology of several neurological diseases such as Alzheimer’s and Pick disease [2–6].